Healthcare entity
Every one of those 1 sits in a single category, market-trends. Of the tracked stories, 1 of 1 also mention Belbuca, the most common co-covered peer. Xtampza ER appears in 1 tracked Healthcare story from March 15, 2026. The tracked stories average 2 original sources each.
Last mentioned: Mar 15, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, market-trends. Of the tracked stories, 1 of 1 also mention Belbuca, the most common co-covered peer. Xtampza ER appears in 1 tracked Healthcare story from March 15, 2026. The tracked stories average 2 original sources each.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 14 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Xtampza ER. Shared-story counts are live from our verified record — not editorial picks.
Eventide Asset Management LLC has reduced its position in Collegium Pharmaceutical, Inc. (COLL), though it maintains a significant $83.65 million stake. This institutional rebalancing occurs as the specialty pharmaceutical sector faces evolving regulatory scrutiny and a transition toward non-opioid pain management solutions.
Source: tickerreport.com · dailypolitical.com
Xtampza ER is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
